Cardiac MRI in Survivorship: When Echocardiography Is Not the Right Answer
Poor acoustic windows, suspected myocarditis, discordant strain, and questions about fibrosis or constriction are where cardiac MRI changes management rather than just adding a scan.
Echocardiography carries most of survivorship surveillance, and it should. Cardiac MRI earns its place in a defined set of questions where echo cannot answer reliably and the answer changes what happens next.
The reproducibility problem
Serial surveillance depends on detecting a real change rather than inter-study variation. In patients with difficult windows, the measurement error can exceed the threshold that would trigger action, which makes the surveillance formally uninformative. Cardiac MRI provides volumes and function with tighter reproducibility and is the sensible substitute in that group rather than repeating an uninterpretable echo.
Where tissue characterisation decides management
Suspected immune checkpoint inhibitor myocarditis is the clearest case: oedema on T2 mapping and late gadolinium enhancement, interpreted with troponin and the clinical picture, support a diagnosis that carries urgent treatment implications. Native T1 and extracellular volume also help where amyloid or another infiltrative process is in the differential, which matters because management diverges sharply.
In constriction versus restriction, MRI adds pericardial thickening and real-time septal interaction to the assessment.
Unexplained decline and discordant strain
When global longitudinal strain falls without an ejection fraction change, or when the echo and the clinical picture disagree, MRI resolves whether there is genuine functional loss, regional abnormality suggesting coronary disease, or fibrosis. Late gadolinium enhancement patterns also carry prognostic information that supports decisions about continuing or holding cardiotoxic therapy.
Practical constraints
Access, cost, breath-hold capacity, claustrophobia, implanted devices, and renal function all limit use, and gadolinium needs consideration where eGFR is reduced. Order it against a specific question, state the exposure history and the clinical decision at stake on the request, and ensure someone is nominated to act on the result.
Frequently asked questions
- When should cardiac MRI be used instead of echocardiography in cancer survivors?
- When acoustic windows are poor, when myocarditis is suspected, when strain and ejection fraction are discordant, and when tissue characterisation is needed to separate inflammation, fibrosis, or infiltration.
- Does cardiac MRI diagnose immune checkpoint inhibitor myocarditis?
- It contributes substantially. Oedema on T2 mapping and late gadolinium enhancement, interpreted alongside troponin and the clinical picture, support the diagnosis and its urgent treatment implications.